Abstract
Many of the chronic wounds are delayed or fail to heal through conventional treatment because attenuated activities of cells responsible for wound healing contribute to the impairment of tissue restoration. The orderly and efficient progression of the wound healing sequence is orchestrated by intercellular communication, much of which is regulated by growth factors and cytokines. Consequently, there is a need for more effective therapy that will stimulate cellular activity of chronic wound patients. Recently, there has been much interest in treating these ulcers with various types of treatment modalities to stimulate cellular functions of chronic wound patients, including growth factors and cell therapies. It has long been hypothesized that using growth factors can promote healing of chronic wounds. Research is currently under way on methods to externally deliver growth factors depleted by diminished cell function in chronic wounds which would therefore facilitate healing; some of these are already being used in clinical settings. Products containing platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF) for topical use on diabetic foot ulcers are some examples. In this chapter, various growth factor therapies that are used clinically to increase cell activities are described.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsFurther Reading
Akasaka Y, Ono I, Yamashita T, et al. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol. 2004;203:710–20.
Akasaka Y, Ono I, Kamiya T, et al. The mechanisms underlying fibroblast apoptosis regulated by growth factors during wound healing. J Pathol. 2010;221:285–99.
Akita S, Akino K, Imaizumi T, Hirano A. A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns. 2005;31:855–8.
Akita S, Akino K, Imaizumi T, et al. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor. J Burn Care Res. 2006;27:333–8.
Akita S, Akino K, Imaizumi T, Hirano A. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen. 2008;16:635–41.
Barnham KJ, Torres AM, Alewood D, et al. Role of the 6–20 disulfide bridge in the structure and activity of epidermal growth factor. Protein Sci. 1998;7:1738–49.
Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem. 1990;265:7709–12.
Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555–62.
Dawson JP, Berger MB, Lin CC, et al. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell Biol. 2005;25:7734–42.
Dreux AC, Lamb DJ, Modjtahedi H, Ferns GA. The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis. Atherosclerosis. 2006;186:38–53.
Eto H, Suga H, Aoi N, et al. Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression. Lab Invest. 2012;92:214–23.
Fallon JH, Seroogy KB, Loughlin SE, et al. Epidermal growth factor immunoreactive material in the central nervous system: location and development. Science. 1984;224:1107–9.
Fernández-Montequín JI, Infante-Cristiá E, Valenzuela-Silva C, et al. Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. Int Wound J. 2007;4:333–43.
Gospodarowicz D. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature. 1974;249:123–7.
Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res. 2003a;284:2–13.
Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res. 2003b;284:2–13.
Hebda PA, Klingbeil CK, Abraham JA, Fiddes JC. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol. 1990;95:626–31.
Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004;59:21–6.
Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg. 2006;56:394–8.
Kanda N, Morimoto N, Takemoto S, et al. Efficacy of novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor for dermis-like tissue regeneration. Ann Plast Surg. 2012;69:569–74.
Kanda N, Morimoto N, Ayvazyan AA, et al. Evaluation of a novel collagen-gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse model. J Tissue Eng Regen Med. 2014;8:29–40.
Kawaguchi H, Jingushi S, Izumi T, et al. Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J Orthop Res. 2007;25:480–7.
Kawai K, Suzuki S, Tabata Y, et al. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials. 2000;21:489–99.
Kitamura M, Akamatsu M, Machigashira M, et al. FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res. 2011;90:35–40.
Kusuhara H, Itani Y, Isogai N, Tabata Y. Randomized controlled trial of the application of topical b-FGF impregnated gelatin microspheres to improve tissue survival in subzone II fingertip amputations. J Hand Surg Eur. 2011;36:455–60.
Lurje G, Lenz HJ. EGFR signaling and drug discovery. Oncology. 2009;77:400–10.
Margolis DJ, Bartus C, Hoffstad O, et al. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair Regen. 2005;13:531–6.
McGee GS, Davidson JM, Buckley A, et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res. 1988;45:145–53.
Ortega S, Ittmann M, Tsang SH, et al. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A. 1998;95:5672–7.
Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A. 1974;71:1207–10.
Senet P, Vicaut E, Beneton N, et al. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Arch Dermatol. 2011;147:926–30.
Stortelers C, Souriau C, van Liempt E, et al. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display. Biochemistry. 2002;41:8732–41.
Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med. 1990;172:245–51.
Tuyet HL, Nguyen Quynh TT, Vo Hoang Minh H, et al. The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results. Int Wound J. 2009;6:159–66.
Uemura T, Watanabe H, Uemura Y. Clinical use of Trafermin (fiblast spray) in pediatric outpatients with burn injuries. Jpn J Burn Inj. 2006;32:291–7.
Urist MR. Bone: formation by auto induction. Science. 1695;150:893–9.
Venturi S, Venturi M. Iodine in evolution of salivary glands and in oral health. Nutr Health. 2009;20:119–34.
Wong L, Deb TB, Thompson SA, et al. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling. J Biol Chem. 1999;274:8900–9.
Yao C, Yao P, Wu H, Zha Z. Acceleration of wound healing in traumatic ulcers by absorbable collagen sponge containing recombinant basic fibroblast growth factor. Biomed Mater. 2006;1:33–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Han, SK. (2016). Growth Factor Therapy. In: Innovations and Advances in Wound Healing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46587-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-46587-5_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46586-8
Online ISBN: 978-3-662-46587-5
eBook Packages: MedicineMedicine (R0)